Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
EMBO Molecular Medicine|February 3, 2025
Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profileAudrey Burban, Cloe Tessier, Mathieu Larroquette, et al.Signal Transduction and Targeted Therapy|May 23, 2026
An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastomaAmir Hossein Mansourabadi, Dianbo Qu, Francesca Cianci, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating GlioblastomaSina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.Journal of Medicinal Chemistry|February 19, 2019
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic CancerAndrew E Shouksmith, Fenil Shah, Michelle L Grimard, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 2019
Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environmentsYaoqing Shen, Cameron J Grisdale, Sumaiya A Islam, et al.Elife|January 11, 2021
Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survivalPaul Guilhamon, Charles Chesnelong, Michelle M Kushida, et al.Proceedings of the National Academy of Sciences of the United States of America|September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.Nature Cancer|February 5, 2022
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneityLaura M Richards, Owen K N Whitley, Graham MacLeod, et al.Nature Communications|February 13, 2021
PRMT5 inhibition disrupts splicing and stemness in glioblastomaPatty Sachamitr, Jolene C Ho, Felipe E Ciamponi, et al.Pageof 4